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Background: It is well known that toll-like receptor 2 (TLR2) mediates responses of both innate
and  adaptive immunity to microbial pathogen, including mycobacteria. Single-nucleotide
polymorphisms (SNPs) in the TLR2 gene that impair its function may be associated with
the  development of pulmonary tuberculosis (PTB). The aim of this study was to evaluate
the  possible association between TLR2 Arg677Trp and 597T/C polymorphisms and PTB in a
sample of Iranian population.
Materials  and methods: This case–control study was performed on 174 PTB and 177 healthy
subjects.  Tetra ampliﬁcation refractory mutation system-polymerase chain reaction (T-
ARMS-PCR) was used to detect the SNPs.
Results: There was no signiﬁcant difference in the polymorphism of Arg677Trp of the TLR2
gene  among PTB and control groups (p > 0.05). The results showed that there was a signiﬁ-
cant  difference between case and control groups regarding 597T/C polymorphism (2 = 12.21,
p = 0.002). The TC and CC genotypes were found to be associated with the risk of PTB
(OR  = 2.13, 95% CI = 1.25–3.62, p = 0.005 and OR = 4.88, 95% CI = 1.56–15.26, p = 0.007, respec-tively).
Conclusion:  Our data suggest that 597T/C polymorphism, but not Arg677Trp polymorphism,
of  the TLR-2 gene is a risk factor for susceptibility to PTB in a sample of Iranian population.
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND∗ Corresponding author.
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ntroduction
uberculosis, caused by Mycobacterium tuberculosis, is a global
ublic  health problem throughout the world especially in
sia  and Africa. Approximately nine million new cases were
eported  in 2008 worldwide (with an incidence of 139/100,000
nhabitants), of which more  than one million died.1 It can
ffect  almost all of the body, including the brain, the kidneys
nd  the bones, but predominately manifests itself in the lungs
here  it is named pulmonary tuberculosis. One-third of the
arth’s  population is infected with tuberculosis (TB) but only
0%  of infected individuals will develop the disease. Increasing
vidence  indicates that host genetic factors play an important
ole  in susceptibility to TB.2
Toll-like receptors (TLRs) are important mediators of the
nﬂammatory response in the ﬁrst line of host defense by
ecognition  of many  pathogen-related molecules and endoge-
ous  proteins associated with immune activation.3–7 TLRs
re  classiﬁed as members of the IL-1R super-family based
n  a shared cytoplasmic region known as the TIR (Toll/IL-1R)
omain.8 TLRs are cell-surface receptors that induce a sig-
al  in the affected cell, involving a number of proteins, such
s  MyD88, IL-1 receptor-associated with extracellular leucine-
ich  domains and an intracellular signaling domain and are
ound  in monocytes, macrophages and neutrophils.9 TLRs
ave  been implicated in the activation of macrophage by a
ariety  of chemically diverse bacterial products (lipopolysac-
haride (LPS), lipoproteins and peptidoglycans)10,11 and kinase
nd  p38 mitogen-activated protein kinase (MAPK).12–15 This
ignaling  cascade leads to NF-B activation, which induces
he  secretion of several proinﬂammatory cytokines16 and has
een  reported to be the chief mediator of macrophage acti-
ation  in response to mycobacteria.17 In vitro studies have
evealed that TLR2 activation directly leads to intracellu-
ar  killing of M.  tuberculosis by alveolar macrophages.18 High
usceptibility to M.  tuberculosis infection of TLR2-deﬁcient
ice19,20 suggests that mutations affecting TLR2 expression
ay  impair host response to this pathogen. In contrast, Sug-
wara  et al. have found that TLR2 does not play an important
ole  in the pathogenesis of murine tuberculosis, though it is
mportant for defense against mycobacterial infection.21 In
ddition  it has been reported that MyD88 deﬁciency did not
nﬂuence  the development of murine tuberculosis.22
To date, there is little and controversial data regarding the
mpact  of TLR2 polymorphism and susceptibility to PTB. It
as  been shown that TLR2 gene (Arg677Trp, Arg753Gln) poly-
orphisms  were  not associated with susceptibility to TB.23
24en-Ali et al. have found that TLR2 Arg677Trp polymorphism
s  a predisposing risk factor for PTB. A signiﬁcant associa-
ion  between TLR2 597T/C polymorphism and tuberculosis has
een found.25 Therefore, the present study aimed to evaluate
Table 1 – Primers used for polymorphism determination of TLR
Primers C2029T (Arg677Trp) 
Forward inner 5′-CCCTTCAAGTTGTGTCTTCATACGT
Reverse inner 5′-TTGCCAGGAATGAAGTCACG-3′
Forward outer 5′-CTGTGCTCTGTTCCTGCTGATC-3′
Reverse outer 5′-TGAGAATGGCAGCATCATTGTT-3′3;1 7(5):516–520  517
the possible association between Arg677Trp and 597T/C poly-
morphisms  of TLR2 and pulmonary tuberculosis in a sample
of  Iranian population.
Materials  and  methods
This case–control study was  performed in the Research Center
for  Infectious Diseases and Tropical Medicine, Bou-Ali Hos-
pital,  Zahedan, Iran. A total of 174 patients with pulmonary
tuberculosis and 177 unrelated healthy subjects were  enrolled
in  the study. The groups were matched for sex and age. The
subjects  who underwent treatment for PTB and newly  diag-
nosed  PTB cases were  enrolled in the study within the case
group.  The diagnosis of PTB was  based on clinical, radiologi-
cal,  sputum Acid Fast Bacillus (AFB) smear positivity, culture,
and  response to antituberculosis chemotherapy as described
previously.26,27 Controls were selected from the Zahedan pop-
ulation  who participated in a metabolic syndrome project
and  have no recent signs, symptoms or history of pulmonary
tuberculosis.
The  project was  approved by the local Ethics Committee
of  the Zahedan University of Medical Sciences, and writ-
ten  informed consent was taken from all participants. Blood
samples  were collected in Na-EDTA tubes from patients and
healthy  controls and stored at −20 ◦C until DNA extraction.
Genomic DNA extraction from blood samples was car-
ried  out as described previously.28 SNPs genotyping of TLR2
Arg677Trp and 597T/C polymorphisms were  performed using
tetra-ARMS-PCR, which is a simple and rapid method for
detection  of SNP.29–32 In this method two external primers
(control band) and two inner primers (allele speciﬁc primers)
are  used as shown in Table 1.
For TLR2 Arg677Trp polymorphism the product sizes were:
199  bp for T allele, 264 bp for C allele and 419 bp for two outer
primers  (control band). The product sizes for detection of
597T/C  polymorphism were: 173 bp for C allele, 228 bp for T
allele  and 349 bp for control band.
Polymerase chain reaction (PCR) was  performed using
commercially available PCR premix (AccuPower PCR PreMix,
BIONEER,  Daejeon, South Korea) according to the manu-
facturer recommended protocol. Into a 0.2-mL PCR tube
containing the AccuPower PCR Pre-Mix, 1 L template DNA
(∼100  ng/L), 1 L of each primer (10 M) and 15 L DNase-free
water were added.
The  PCR cycling condition for 597T/C was  5 min  at 95 ◦C
followed by 30 cycles of 30 s at 95 ◦C, 30 s at 53 ◦C and 30 s at
72 ◦C. The PCR condition for detection of Arg677Trp polymor-
◦phism  was  95 C for 5 min  followed by 30 cycles, consisting of
denaturation  at 95 ◦C for 40 s, annealing at 55 ◦C for 20 s, and
extension at 72 ◦C for 45 s with a ﬁnal step at 72 ◦C for 10 min
to  allow for complete extension of all PCR fragments. The PCR
2.
597T/C (rs3804099)
-3′ 5′-CCAAAAAGTTTGAAGTCAATTCAGCAT-3′
5′-TCATATGAAGGATCAGATGACTTCCG-3′
5′-ATTGCAAATCCTGAGAGTGGGAA-3′
5′-CAAACTTTCATCGGTGATTTTCACA-3′
518  b r a z j i n f e c t d i s . 2 0 1 3;1  7(5):516–520
500 bp
A B
400 bp
400 bp
300 bp
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200 bp
200 bp
100 bp 100 bp
M MCC CCCC CCCT TC TC TTCT CT
rp (rFig. 1 – Photograph of the PCR products of the TLR2 Arg677T
marker.
products were  analyzed by electrophoresis on a 2% agarose
gel  containing 0.5 g/ml ethidium bromide and visualized by
transillumination with UV light and photograph was taken
(Fig.  1). We  regenotyped approximately 20% of the samples
to  verify the initial results. The check conﬁrmed the previous
genotyping results by 100%.
Statistical  analysis
The statistical analysis of the data was  performed using the
SPSS  18.0 software. Demographics and biochemical param-
eters  between the groups were analyzed by independent
sample t-test for continuous data and 2 test for categorical
data. The associations between genotypes and PTB were esti-
mated  by computing the odds ratio (OR) and 95% conﬁdence
intervals (95% CI) from logistic regression analyses.
Results
Of the 174 study patients, 110 (63.2%) were  female and 64
(36.8%)  male. In uninfected group, 97 (54.8%) were female and
80  (45.2%) were  male. The mean ± SD ages for cases and con-
trols  were  50.17 ± 20.47 and 46.88 ± 15.45, respectively. There
was  no signiﬁcant difference among the groups regarding sex
and age (p > 0.05).
The genotype and allele frequencies of TLR2 polymor-
phisms in patient and control groups were  summarized in
Table  2.
The  wild-type genotype 677 Arg/Arg was  observed in 134
(47.0%)  of the patients, whereas 40 (23.0%) were  heterozygous
(677  Arg/Trp). In the control group, the frequencies of geno-
types  were  148 (83.6%) for Arg/Arg and 29 (16.4%) for Arg/Trp.
No  one in either group was  homozygous for the mutant geno-
type  (Trp/Trp). No signiﬁcant association was  found between
the  groups regarding 677 Arg/Trp (C/T) polymorphism of TLR2
(OR  = 1.52, 95% CI = 0.88–2.58, p = 0.135).
Our ﬁnding showed that there was  a signiﬁcant dif-
ference between case and control groups regarding TLR2
597T/C  polymorphism (2 = 12.21, p = 0.002). The TLR2 597T/Cs1695 A/G) gene (A) and 597T/C polymorphism (B). M, DNA
polymorphism was  a risk predisposing factor for PTB in
codominant (OR = 2.13, 95%CI = 1.25–3.62, p = 0.005, TT vs TC;
OR  = 4.88, 95% CI = 1.56–15.26, p = 0.007, TT vs CC) and dom-
inant  (OR = 2.24, 95% CI = 1.32–3.79, p = 0.003, TT vs TC-CC)
tested inheritance models (Table 2).
Allele frequencies for T and C were found to be 0.54 and
0.46  in the PTB group and 0.63 and 0.37 in the control group,
respectively. The C allele was  a predisposing risk factor for PTB
(OR = 1.5, 95% CI = 1.1–2.0, p = 0.014).
Discussion
In the present study, we have investigated the impact
of  TLR2 polymorphisms at position 597T/C and missense
mutation affecting the intracellular domain of human TLR2
Arg677Trp  (C2029T) and susceptibility to PTB in a sample
of  Iranian population. A signiﬁcant difference was  found
between patients with PTB and healthy controls regarding
TLR2  597T/C polymorphism genotype and allelic distribution.
No  signiﬁcant difference was  found between the groups con-
cerning  Arg677Trp (C2029T) polymorphism in our population.
In  agreement with our ﬁnding Xue et al.23 have found no asso-
ciation  between Arg677Trp polymorphism of TLR2 and PTB
in  the southeastern Chinese population. On the other hand,
Schroder  et al.33 have shown that no individual was  identiﬁed
carrying the Arg677Trp polymorphism in Germany. In contrast
to  our ﬁndings Ben-Ali et al.24 have found that TLR2 Arg677Trp
polymorphism (C2029T) is a predisposing risk factor for PTB.
In  line with the present study, they found no subject in either
group  to be homozygous for the mutant genotype (Trp/Trp).
Concerning the 597T/C, Thuong et al.25 have found that
597CC genotype was  associated with tuberculosis in Vietnam.
Our  results are consistent with their ﬁnding. The 597TC and
CC  genotypes were  found to be associated with PTB risk in our
population.
Caws  et al.34 have found that individuals with the 597C
allele of TLR-2 were more  likely to have tuberculosis caused
by  the East-Asian/Beijing genotype than other individuals.
Lorenz et al.35 reported a single nucleotide polymorphism
in the TLR2 gene (arginine to glutamine) substitution at
b r a z j i n f e c t d i s . 2 0 1 3;1 7(5):516–520  519
Table 2 – The genotypes and allele distribution of TLR2 polymorphism in case (pulmonary tuberculosis) and control
groups.
Polymorphism Case, n (%) Control, n (%) OR (95% CI) p aOR (95% CI) p
2029C/T (Arg677Trp)
CC  134 (77.0) 148 (83.6) Reference Reference
CT 40 (23.0) 29 (16.4) 1.52 (0.90–2.59) 0.121 1.51 (0.88–2.58) 0.135
TT 0 (0) 0 (0) – – – –
Alleles
C 308 (88.5) 325 (91.8)
T 40 (11.5) 29 (8.2) 1.45 (0.88–2.41) 0.163
597T/C
Codominant
TT 27 (15.5) 52 (29.4) Reference Reference
TC 134 (77.0) 120 (67.8) 2.15 (1.27–3.64) 0.004 2.13 (1.25–3.62) 0.005
CC 13 (7.5) 5 (2.8) 5.0 (1.62–15.52) 0.005 4.88 (1.56–15.26) 0.007
Dominant
TT 27 (15.5) 52 (29.4) Reference Reference
TC + CC 147 (84.5) 125 (70.6) 2.27 (1.34–3.82) 0.002 2.24 (1.32–3.79) 0.003
Recessive
TT + TC 161 (92.5) 172 (97.2) Reference Reference
CC 13 (7.5) 5 (2.8) 2.78 (0.97–7.97) 0.057 2.72 (0.94–7.86) 0.065
Alleles
T 188 (54.0) 224 (63.2)
C 160 (46.0) 130 (36.8) 1.5 (1.1–2.0) 0.014
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esidue 753 (Arg753Gln) that leads to a decreased response
f  macrophages to bacterial peptides, resulting in an atten-
ated  immune response in the host. It has previously been
emonstrated that the TLR2 polymorphism results in a
ecreased  ability of macrophages to respond to several bac-
erial  peptides.35
Ogus et al.36 have found that Arg753Gln polymorphism of
he  TLR2 gene inﬂuences the risk of developing tuberculosis.
here is no clear explanation for these discrepancies, but may
eﬂect  differences in genetic background among the study
opulations.
Tuberculosis kills more  people each year than any other
ingle  infectious disease. It has been proposed that develop-
ent  of tuberculosis disease depends on interaction between
he  pathogen, environment, and the host. Many studies sup-
ort  that the differences in host immune genes accompanies
usceptibility/resistance to TB.37,38
The host’s immune response to M. tuberculosis is mainly
ediated by a TLR2 signaling in macrophages, which leads
o  direct bactericidal effect by suppressing the prolifera-
ion of M. tuberculosis or induction of apoptosis of infected
acrophages.39
The ﬁndings of this study might be limited by the relatively
mall  sample size and therefore our limited statistical power
nalysis.
In  conclusion, our ﬁndings in a sample of Iranian popu-
ation  provide evidence that 597T/C polymorphism, but not
rg677Trp  polymorphism, of the TLR-2 gene is a risk factor for
usceptibility to pulmonary tuberculosis.onﬂict  of  interest
he authors declare no conﬂict of interest.
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